NCT01337011 - Intra-coronary Versus Intramyocardial Application of Enriched CD133pos Autologous Bone Marrow Derived Stem Cells | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

March 2, 2016

Study Completion Date

July 17, 2017

Conditions

Heart Failure

Interventions

OTHER

autologous CD133pos stem cell application

The study aims to show efficacy of both intra-myocardial autologous CD133pos bone marrow cell application as well as intra-coronary CD133pos cell application in patients with symptomatic ischemic heart disease. In addition, efficacy between the two delivery routes will be compared.

Trial Locations (1)

20099

ASKLEPIOS Klinik St. Georg, Hamburg